[Elsevier] Breaking barriers in brexpiprazole bioequivalence: a first-in-human UPLC-MS/MS approach to circumvent clinical sampling constraints |
|
This post will be closed automatically in 2026-07-28 15:21
Reward10points
|
20
Ischemia-induced p300-dependent histone lactylation activates an AP-1每SPP1 program in microglia to exacerbate ischemic brain injury
10
Seasonal variation in wing morphometry of the stable fly Stomoxys calcitrans (Diptera: Muscidae) in Thailand: Climatic effects on phenotypic traits
100
[Full book]Food Process Engineering and Technology
20
Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial
100
[Full book]Food Processing Technology Principles and Practice
